🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer.
Learn more: ior.usi.ch/events-news/...
🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer.
Learn more: ior.usi.ch/events-news/...
-Epigenetic vulnerabilities in marginal zone lymphoma
doi.org/10.1158/1535...
@iorbellinzona.bsky.social @usi.ch
-Epigenetic vulnerabilities in marginal zone lymphoma
doi.org/10.1158/1535...
@iorbellinzona.bsky.social @usi.ch
An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma.
Learn more: ior.usi.ch/events-news/...
An international study conducted by the IOR Experimental Hematology Laboratory, led by Prof. Davide Rossi, offers a new perspective on the genetics of classical Hodgkin lymphoma.
Learn more: ior.usi.ch/events-news/...
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
doi.org/10.1182/bloo...
doi.org/10.1182/bloo...
ascopost.com/issues/june-...
ascopost.com/issues/june-...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/...
chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/...
«What's new in lymphoid neoplasias?», Bellinzona, Switzerland, February 2026
www.lymphomaforum.ch
«What's new in lymphoid neoplasias?», Bellinzona, Switzerland, February 2026
www.lymphomaforum.ch
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.
Learn more: tinyurl.com/ytybcbr8
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.
Learn more: tinyurl.com/ytybcbr8
en.wikipedia.org/wiki/Project...
en.wikipedia.org/wiki/Project...
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #ESMOGuidelines
🔗 buff.ly/2ZYJc2c
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #ESMOGuidelines
🔗 buff.ly/2ZYJc2c
www.esmo.org/guidelines/e...
www.esmo.org/guidelines/e...
If #CRISPRscreens, #syntheticlethality, #smallmolecules & #celldeath excite you, let’s talk! DMs welcome.
pls share 🙏
If #CRISPRscreens, #syntheticlethality, #smallmolecules & #celldeath excite you, let’s talk! DMs welcome.
pls share 🙏
blogs.hear2care.org/patientresou...
blogs.hear2care.org/patientresou...
ultimateclassicrock.com/david-bowie-...
ultimateclassicrock.com/david-bowie-...
www.udiscovermusic.com/stories/soni...
www.udiscovermusic.com/stories/soni...
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...